CB Therapeutics

Fermentation-derived natural products to solve health problems

Y CombinatorSummer 2018ActiveHealthcareIndustrial BioCellular AgricultureBiotech

What they do

Problem

Mental health and pain conditions such as depression, PTSD, addiction, and chronic pain lack sufficient effective therapeutic options.

Solution

The company uses synthetic biology fermentation to produce cannabinoid and tryptamine-based therapeutics for clinical and commercial use.

Who it's for

Pharmaceutical companies, clinicians, and healthcare systems treating patients with mental health, addiction, and pain disorders.

Founders

Sher Butt

Founder/CEO

Jacob Vogan

Founder

Co-founded CB Therapeutics to create new biological supply chains for rare natural products that can help treat disease, increase healthspan, and promote longevity.

Company timeline

YC batchSummer 2018
StatusActive
Team size18 people
LocationSan Diego, CA, USA

Similar startups

Humane Genomics

A platform to make artificial viruses as cancer therapeutics.

Persephone Biosciences

We are using the gut microbiome to end cancer.

Equator Therapeutics

We are developing a drug to burn calories and increase metabolism…

Rejuvenation Technologies Inc.

mRNA therapeutics to extend healthspan entering clinical trials

Promakhos Therapeutics

A therapeutics platform for curing inflammatory disorders

SynsoryBio

"If-then" conditional logic for protein drugs